Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 636

1.

Reporting bias in the literature on the associations of health-related behaviors and statins with cardiovascular disease and all-cause mortality.

Rezende LFM, Rey-López JP, Sá TH, Chartres N, Fabbri A, Powell L, Stamatakis E, Bero L.

PLoS Biol. 2018 Jun 18;16(6):e2005761. doi: 10.1371/journal.pbio.2005761. [Epub ahead of print]

2.

Cell Propagation of Cholera Toxin CTA ADP-Ribosylating Factor by Exosome Mediated Transfer.

Zanetti C, Gallina A, Fabbri A, Parisi S, Palermo A, Fecchi K, Boussadia Z, Carollo M, Falchi M, Pasquini L, Fiani ML, Sargiacomo M.

Int J Mol Sci. 2018 May 19;19(5). pii: E1521. doi: 10.3390/ijms19051521.

3.

Rituximab plus Bendamustine as front line treatment in frail elderly (>70 years) patients with diffuse large B-cell non-Hodgkin's lymphoma: a phase II multicenter study of the Fondazione Italiana Linfomi.

Storti S, Spina M, Pesce EA, Salvi F, Merli M, Ruffini A, Cabras G, Chiappella A, Angelucci E, Fabbri A, Liberati AM, Tani M, Musuraca G, Molinari A, Petrilli MP, Palladino C, Ciancia R, Ferrario A, Gasbarrino C, Monaco F, Fraticelli V, De Vellis A, Merli F, Luminari S.

Haematologica. 2018 May 10. pii: haematol.2017.186569. doi: 10.3324/haematol.2017.186569. [Epub ahead of print]

4.

The Bacterial Toxin CNF1 Induces Activation and Maturation of Human Monocyte-Derived Dendritic Cells.

Gall-Mas L, Fabbri A, Namini MRJ, Givskov M, Fiorentini C, Krejsgaard T.

Int J Mol Sci. 2018 May 8;19(5). pii: E1408. doi: 10.3390/ijms19051408.

5.

New therapeutics from Nature: The odd case of the bacterial cytotoxic necrotizing factor 1.

Maroccia Z, Loizzo S, Travaglione S, Frank C, Fabbri A, Fiorentini C.

Biomed Pharmacother. 2018 May;101:929-937. doi: 10.1016/j.biopha.2018.02.140. Epub 2018 Mar 22. Review.

PMID:
29635902
6.

Author Correction: Establishment of patient derived xenografts as functional testing of lung cancer aggressiveness.

Moro M, Bertolini G, Caserini R, Borzi C, Boeri M, Fabbri A, Leone G, Gasparini P, Galeone C, Pelosi G, Roz L, Sozzi G, Pastorino U.

Sci Rep. 2018 Feb 27;8(1):3965. doi: 10.1038/s41598-018-21279-z.

7.

Integrated Cancer Treatment in the Course of Metastatic Pancreatic Cancer: Complete Resolution in 2 Cases.

Bonucci M, Pastore C, Ferrera V, Fiorentini C, Fabbri A.

Integr Cancer Ther. 2018 Feb 1:1534735418755479. doi: 10.1177/1534735418755479. [Epub ahead of print]

PMID:
29478350
8.

Potential use of ricotta cheese whey for the production of lactobionic acid by Pseudomonas taetrolens strains.

De Giorgi S, Raddadi N, Fabbri A, Gallina Toschi T, Fava F.

N Biotechnol. 2018 May 25;42:71-76. doi: 10.1016/j.nbt.2018.02.010. Epub 2018 Feb 21.

PMID:
29476816
9.

How Deep the Sea Is.

Elia F, Fabbri A, Aprà F.

Ann Emerg Med. 2018 Mar;71(3):422-423. doi: 10.1016/j.annemergmed.2017.08.067. No abstract available.

PMID:
29458800
10.

Does industry-sponsored education foster overdiagnosis and overtreatment of depression, osteoporosis and over-active bladder syndrome? An Australian cohort study.

Mintzes B, Swandari S, Fabbri A, Grundy Q, Moynihan R, Bero L.

BMJ Open. 2018 Feb 13;8(2):e019027. doi: 10.1136/bmjopen-2017-019027.

11.

COPD exacerbations in the emergency department: Epidemiology and related costs. A retrospective cohort multicentre study from the Italian Society of Emergency Medicine (SIMEU).

Germini F, Veronese G, Marcucci M, Coen D, Ardemagni D, Montano N, Fabbri A; SIMEU Study Group.

Eur J Intern Med. 2018 May;51:74-79. doi: 10.1016/j.ejim.2018.01.010. Epub 2018 Jan 20.

PMID:
29371059
12.

Long-term efficacy and toxicity of rituximab plus fludarabine and mitoxantrone (R-FM) for gastric marginal zone lymphoma: a single-center experience and literature review.

Cencini E, Fabbri A, Lauria F, Bocchia M.

Ann Hematol. 2018 May;97(5):821-829. doi: 10.1007/s00277-018-3243-7. Epub 2018 Jan 16. Review.

PMID:
29340761
13.

The Risk of Deterioration in GCS13-15 Patients with Traumatic Brain Injury Identified by Computed Tomography Imaging: A Systematic Review and Meta-Analysis.

Marincowitz C, Lecky FE, Townend W, Borakati A, Fabbri A, Sheldon TA.

J Neurotrauma. 2018 Mar 1;35(5):703-718. doi: 10.1089/neu.2017.5259. Epub 2018 Jan 11.

14.

Preclinical Antileukemia Activity of Tramesan: A Newly Identified Bioactive Fungal Metabolite.

Ricciardi MR, Licchetta R, Mirabilii S, Scarpari M, Parroni A, Fabbri AA, Cescutti P, Reverberi M, Fanelli C, Tafuri A.

Oxid Med Cell Longev. 2017;2017:5061639. doi: 10.1155/2017/5061639. Epub 2017 Nov 15.

15.

Durable response after VNCOP-B and rituximab in an elderly patient with high-grade B-cell lymphoma.

Cencini E, Fabbri A, Schiattone L, Gentili F, Mazzei MA, Bocchia M.

Acta Clin Belg. 2017 Dec 6:1-5. doi: 10.1080/17843286.2017.1412888. [Epub ahead of print]

PMID:
29212420
16.

Estimating the risk of severe hypoglycemic event related to glucose-lowering treatment among Italian patients with diabetes: the HYPOTHESIS database.

Mazzi S, Ravasio R, Forlani G, Veronese G, Fabbri A, Marchesini G.

Clinicoecon Outcomes Res. 2017 Nov 21;9:711-720. doi: 10.2147/CEOR.S148368. eCollection 2017.

17.

Bilateral Parotid Gland Metastases from Gastric Signet-Ring Cell Carcinoma.

Nichetti F, Morano F, Fabbri A, de Braud F, Di Bartolomeo M.

Tumori. 2017 Nov 1:tj5000690. doi: 10.5301/tj.5000690. [Epub ahead of print]

PMID:
29192740
18.

Position paper on vegetarian diets from the working group of the Italian Society of Human Nutrition.

Agnoli C, Baroni L, Bertini I, Ciappellano S, Fabbri A, Papa M, Pellegrini N, Sbarbati R, Scarino ML, Siani V, Sieri S.

Nutr Metab Cardiovasc Dis. 2017 Dec;27(12):1037-1052. doi: 10.1016/j.numecd.2017.10.020. Epub 2017 Oct 31. Review.

19.

High yield purification and first structural characterization of the full-length bacterial toxin CNF1.

Colarusso A, Caterino M, Fabbri A, Fiorentini C, Vergara A, Sica F, Parrilli E, Tutino ML.

Biotechnol Prog. 2018 Jan;34(1):150-159. doi: 10.1002/btpr.2574. Epub 2017 Nov 14.

PMID:
29063721
20.

Whole-brain radiotherapy or autologous stem-cell transplantation as consolidation strategies after high-dose methotrexate-based chemoimmunotherapy in patients with primary CNS lymphoma: results of the second randomisation of the International Extranodal Lymphoma Study Group-32 phase 2 trial.

Ferreri AJM, Cwynarski K, Pulczynski E, Fox CP, Schorb E, La Rosée P, Binder M, Fabbri A, Torri V, Minacapelli E, Falautano M, Ilariucci F, Ambrosetti A, Roth A, Hemmaway C, Johnson P, Linton KM, Pukrop T, Sønderskov Gørløv J, Balzarotti M, Hess G, Keller U, Stilgenbauer S, Panse J, Tucci A, Orsucci L, Pisani F, Levis A, Krause SW, Schmoll HJ, Hertenstein B, Rummel M, Smith J, Pfreundschuh M, Cabras G, Angrilli F, Ponzoni M, Deckert M, Politi LS, Finke J, Reni M, Cavalli F, Zucca E, Illerhaus G; International Extranodal Lymphoma Study Group (IELSG).

Lancet Haematol. 2017 Nov;4(11):e510-e523. doi: 10.1016/S2352-3026(17)30174-6. Epub 2017 Oct 17.

PMID:
29054815
21.

Radiotherapy plus rituximab as first-line regimen for localized follicular lymphoma.

Cencini E, Puccini B, Rigacci L, Fabbri A, Kovalchuk S, Mannelli L, Benelli G, Carfagno T, Simontacchi G, Bocchia M, Bosi A.

Leuk Lymphoma. 2018 Jun;59(6):1420-1426. doi: 10.1080/10428194.2017.1387909. Epub 2017 Oct 10.

PMID:
28994343
22.

Anthropometric, clinical and molecular determinants of treatment outcomes in postmenopausal, hormone receptor positive metastatic breast cancer patients treated with fulvestrant: Results from a real word setting.

Pizzuti L, Natoli C, Gamucci T, Mauri M, Sergi D, Di Lauro L, Paoletti G, Ruggeri E, Iezzi L, Sperduti I, Mentuccia L, Fabbri A, Maugeri-Saccà M, Moscetti L, Barba M, Vici P.

Oncotarget. 2017 Apr 9;8(40):69025-69037. doi: 10.18632/oncotarget.16982. eCollection 2017 Sep 15.

23.

Efficacy and safety of T-DM1 in the 'common-practice' of HER2+ advanced breast cancer setting: a multicenter study.

Fabi A, De Laurentiis M, Caruso M, Valle E, Moscetti L, Santini D, Cannita K, Carbognin L, Ciccarese M, Rossello R, Arpino G, Leonardi V, Montemurro F, La Verde N, Generali D, Zambelli A, Scandurra G, Russillo M, Paris I, D'Ottavio AM, Filippelli G, Giampaglia M, Stani S, Fabbri A, Alesini D, Cianniello D, Giannarelli D, Cognetti F.

Oncotarget. 2017 Mar 18;8(38):64481-64489. doi: 10.18632/oncotarget.16373. eCollection 2017 Sep 8.

24.

Testicular and thyroid function as survival predictors in the elderly patient candidate to surgery.

Aversa A, Fabbri A.

Monaldi Arch Chest Dis. 2017 Jul 18;87(2):841. doi: 10.4081/monaldi.2017.841.

25.

Uncommon somatic mutations in metastatic NUT midline carcinoma.

Cavalieri S, Stathis A, Fabbri A, Sonzogni A, Perrone F, Tamborini E, Pelosi G, de Braud F, Platania M.

Tumori. 2017 Nov 15;103(Suppl. 1):e5-e8. doi: 10.5301/tj.5000685.

PMID:
28967088
26.

How health service delivery guides the allocation of major trauma patients in the intensive care units of the inclusive (hub and spoke) trauma system of the Emilia Romagna Region (Italy). A cross-sectional study.

Chieregato A, Volpi A, Gordini G, Ventura C, Barozzi M, Caspani MLR, Fabbri A, Ferrari AM, Ferri E, Giugni A, Marino M, Martino C, Pizzamiglio M, Ravaldini M, Russo E, Trabucco L, Trombetti S, De Palma R.

BMJ Open. 2017 Sep 29;7(9):e016415. doi: 10.1136/bmjopen-2017-016415.

27.

A retrospective multicentric observational study of trastuzumab emtansine in HER2 positive metastatic breast cancer: a real-world experience.

Vici P, Pizzuti L, Michelotti A, Sperduti I, Natoli C, Mentuccia L, Di Lauro L, Sergi D, Marchetti P, Santini D, Magnolfi E, Iezzi L, Moscetti L, Fabbri A, Cassano A, Grassadonia A, Omarini C, Piacentini F, Botticelli A, Bertolini I, Scinto AF, Zampa G, Mauri M, D'Onofrio L, Sini V, Barba M, Maugeri-Saccà M, Rossi E, Landucci E, Tomao S, Alberti AM, Giotta F, Ficorella C, Adamo V, Russo A, Lorusso V, Cannita K, Barni S, Laudadio L, Greco F, Garrone O, Della Giulia M, Marolla P, Sanguineti G, Di Cocco B, Ciliberto G, De Maria R, Gamucci T.

Oncotarget. 2017 May 25;8(34):56921-56931. doi: 10.18632/oncotarget.18176. eCollection 2017 Aug 22.

28.

Impact of Adrenal Steroids on Regulation of Adipose Tissue.

Infante M, Armani A, Mammi C, Fabbri A, Caprio M.

Compr Physiol. 2017 Sep 12;7(4):1425-1447. doi: 10.1002/cphy.c160037. Review.

PMID:
28915330
29.

Study sponsorship and the nutrition research agenda: analysis of cohort studies examining the association between nutrition and obesity.

Fabbri A, Chartres N, Bero LA.

Public Health Nutr. 2017 Dec;20(17):3193-3199. doi: 10.1017/S1368980017002178. Epub 2017 Aug 30.

PMID:
28851466
30.

The significance of serum immunoglobulin paraprotein in diffuse large B-cell lymphoma.

Cox MC, Di Napoli A, Fabbri A, Cencini E, Ruco L.

Br J Haematol. 2017 Aug 17. doi: 10.1111/bjh.14873. [Epub ahead of print] No abstract available.

PMID:
28832947
31.

Establishment of patient derived xenografts as functional testing of lung cancer aggressiveness.

Moro M, Bertolini G, Caserini R, Borzi C, Boeri M, Fabbri A, Leone G, Gasparini P, Galeone C, Pelosi G, Roz L, Sozzi G, Pastorino U.

Sci Rep. 2017 Jul 27;7(1):6689. doi: 10.1038/s41598-017-06912-7. Erratum in: Sci Rep. 2018 Feb 27;8(1):3965.

32.

Lenalidomide and Temozolomide Combination in a Very Elderly Patient with CNS Relapse of Diffuse Large B-Cell Lymphoma.

Cencini E, Fabbri A, Arrigucci U, Cerase A, Bocchia M.

Mediterr J Hematol Infect Dis. 2017 Jun 16;9(1):e2017040. doi: 10.4084/MJHID.2017.040. eCollection 2017.

33.

New perspectives for patients with primary CNS lymphoma.

Fabbri A, Cencini E, Cerase A, Bocchia M.

Radiother Oncol. 2017 Aug;124(2):331-332. doi: 10.1016/j.radonc.2017.04.027. Epub 2017 Jul 4. No abstract available.

PMID:
28687399
34.

A cross-sectional analysis of pharmaceutical industry-funded events for health professionals in Australia.

Fabbri A, Grundy Q, Mintzes B, Swandari S, Moynihan R, Walkom E, Bero LA.

BMJ Open. 2017 Jun 30;7(6):e016701. doi: 10.1136/bmjopen-2017-016701.

35.

Acute Heart Failure in the Emergency Department: the SAFE-SIMEU Epidemiological Study.

Fabbri A, Marchesini G, Carbone G, Cosentini R, Ferrari A, Chiesa M, Bertini A, Rea F; Italian Society of Emergency Medicine (SIMEU).

J Emerg Med. 2017 Aug;53(2):178-185. doi: 10.1016/j.jemermed.2017.03.030. Epub 2017 May 10.

PMID:
28501384
36.

FNA and CNB in the diagnosis of pulmonary lesions: a single-center experience on 665 patients, comparison between two periods.

Marchianò AV, Cosentino M, Di Tolla G, Greco FG, Silva M, Sverzellati N, Fabbri A, Tamborini E, Lo Russo G, Mariani L, Lalli L, Pastorino U.

Tumori. 2017 Jul 31;103(4):360-366. doi: 10.5301/tj.5000633. Epub 2017 Apr 28.

PMID:
28478642
37.

Prognostic role of M2 tumour-associated macrophages in lymphoproliferative disorders.

Cencini E, Fabbri A, Bocchia M.

J Pathol. 2017 Aug;242(4):511-512. doi: 10.1002/path.4914. Epub 2017 Jul 10. No abstract available.

PMID:
28466475
38.

Thymus neuroendocrine tumors with CTNNB1 gene mutations, disarrayed ß-catenin expression, and dual intra-tumor Ki-67 labeling index compartmentalization challenge the concept of secondary high-grade neuroendocrine tumor: a paradigm shift.

Fabbri A, Cossa M, Sonzogni A, Bidoli P, Canova S, Cortinovis D, Abbate MI, Calabrese F, Nannini N, Lunardi F, Rossi G, La Rosa S, Capella C, Tamborini E, Perrone F, Busico A, Capone I, Valeri B, Pastorino U, Albini A, Pelosi G.

Virchows Arch. 2017 Jul;471(1):31-47. doi: 10.1007/s00428-017-2130-2. Epub 2017 Apr 27.

PMID:
28451756
39.

Pulmonary adenocarcinoma with mucin production modulates phenotype according to common genetic traits: a reappraisal of mucinous adenocarcinoma and colloid adenocarcinoma.

Sonzogni A, Bianchi F, Fabbri A, Cossa M, Rossi G, Cavazza A, Tamborini E, Perrone F, Busico A, Capone I, Picciani B, Valeri B, Pastorino U, Pelosi G.

J Pathol Clin Res. 2017 Mar 22;3(2):139-152. doi: 10.1002/cjp2.67. eCollection 2017 Apr.

40.

Quantum Backreaction on Three-Dimensional Black Holes and Naked Singularities.

Casals M, Fabbri A, Martínez C, Zanelli J.

Phys Rev Lett. 2017 Mar 31;118(13):131102. doi: 10.1103/PhysRevLett.118.131102. Epub 2017 Mar 30.

PMID:
28409965
41.

Alpha-fetoprotein elevation in NUT midline carcinoma: a case report.

D'Ambrosio L, Palesandro E, Moretti M, Pelosi G, Fabbri A, Carnevale Schianca F, Aglietta M, Grignani G.

BMC Cancer. 2017 Apr 13;17(1):266. doi: 10.1186/s12885-017-3262-0.

42.

Vitamin D in amyotrophic lateral sclerosis.

Libonati L, Onesti E, Gori MC, Ceccanti M, Cambieri C, Fabbri A, Frasca V, Inghilleri M.

Funct Neurol. 2017 Jan/Mar;32(1):35-40.

43.

The effect of parathyroid hormone (1-84) treatment on serum bone morphogenetic protein 4 and vascular endothelial growth factor in postmenopausal women with established osteoporosis.

Pepe J, Cipriani C, Cantatore FP, Fabbri A, Pola E, Vinicola V, Raimo O, Biamonte F, Pascone R, Ferrara C, Minisola S.

J Endocrinol Invest. 2017 Jun;40(6):663-667. doi: 10.1007/s40618-017-0636-8. Epub 2017 Feb 25.

PMID:
28238166
44.

Lenalidomide maintenance in patients with relapsed diffuse large B-cell lymphoma who are not eligible for autologous stem cell transplantation: an open label, single-arm, multicentre phase 2 trial.

Ferreri AJ, Sassone M, Zaja F, Re A, Spina M, Rocco AD, Fabbri A, Stelitano C, Frezzato M, Rusconi C, Zambello R, Couto S, Ren Y, Arcari A, Bertoldero G, Nonis A, Scarfò L, Calimeri T, Cecchetti C, Chiozzotto M, Govi S, Ponzoni M.

Lancet Haematol. 2017 Mar;4(3):e137-e146. doi: 10.1016/S2352-3026(17)30016-9. Epub 2017 Feb 17.

PMID:
28219694
45.

Progression of motor deficits in glioma-bearing mice: impact of CNF1 therapy at symptomatic stages.

Vannini E, Maltese F, Olimpico F, Fabbri A, Costa M, Caleo M, Baroncelli L.

Oncotarget. 2017 Apr 4;8(14):23539-23550. doi: 10.18632/oncotarget.15328.

46.

Computational analysis of the human sinus node action potential: model development and effects of mutations.

Fabbri A, Fantini M, Wilders R, Severi S.

J Physiol. 2017 Apr 1;595(7):2365-2396. doi: 10.1113/JP273259.

47.

Essential role of ICAM-1 in aldosterone-induced atherosclerosis.

Marzolla V, Armani A, Mammi C, Moss ME, Pagliarini V, Pontecorvo L, Antelmi A, Fabbri A, Rosano G, Jaffe IZ, Caprio M.

Int J Cardiol. 2017 Apr 1;232:233-242. doi: 10.1016/j.ijcard.2017.01.013. Epub 2017 Jan 5.

48.

Ki-67 labeling index of neuroendocrine tumors of the lung has a high level of correspondence between biopsy samples and surgical specimens when strict counting guidelines are applied.

Fabbri A, Cossa M, Sonzogni A, Papotti M, Righi L, Gatti G, Maisonneuve P, Valeri B, Pastorino U, Pelosi G.

Virchows Arch. 2017 Feb;470(2):153-164. doi: 10.1007/s00428-016-2062-2. Epub 2017 Jan 4.

49.

Study sponsorship and the nutrition research agenda: analysis of randomized controlled trials included in systematic reviews of nutrition interventions to address obesity.

Fabbri A, Chartres N, Scrinis G, Bero LA.

Public Health Nutr. 2017 May;20(7):1306-1313. doi: 10.1017/S1368980016003128. Epub 2016 Dec 19. Review.

PMID:
27989264
50.

Functional Analyses of the Crohn's Disease Risk Gene LACC1.

Assadi G, Vesterlund L, Bonfiglio F, Mazzurana L, Cordeddu L, Schepis D, Mjösberg J, Ruhrmann S, Fabbri A, Vukojevic V, Percipalle P, Salomons FA, Laurencikiene J, Törkvist L, Halfvarson J, D'Amato M.

PLoS One. 2016 Dec 13;11(12):e0168276. doi: 10.1371/journal.pone.0168276. eCollection 2016.

Supplemental Content

Loading ...
Support Center